BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 16631083)

  • 1. Dual optical and nuclear imaging in human melanoma xenografts using a single targeted imaging probe.
    Li C; Wang W; Wu Q; Ke S; Houston J; Sevick-Muraca E; Dong L; Chow D; Charnsangavej C; Gelovani JG
    Nucl Med Biol; 2006 Apr; 33(3):349-58. PubMed ID: 16631083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Near-infrared optical imaging of integrin alphavbeta3 in human tumor xenografts.
    Wang W; Ke S; Wu Q; Charnsangavej C; Gurfinkel M; Gelovani JG; Abbruzzese JL; Sevick-Muraca EM; Li C
    Mol Imaging; 2004 Oct; 3(4):343-51. PubMed ID: 15802051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality analysis of in vivo near-infrared fluorescence and conventional gamma images acquired using a dual-labeled tumor-targeting probe.
    Houston JP; Ke S; Wang W; Li C; Sevick-Muraca EM
    J Biomed Opt; 2005; 10(5):054010. PubMed ID: 16292970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technetium-99m-labeled Arg-Gly-Asp-conjugated alpha-melanocyte stimulating hormone hybrid peptides for human melanoma imaging.
    Yang J; Guo H; Miao Y
    Nucl Med Biol; 2010 Nov; 37(8):873-83. PubMed ID: 21055617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer.
    Sampath L; Kwon S; Ke S; Wang W; Schiff R; Mawad ME; Sevick-Muraca EM
    J Nucl Med; 2007 Sep; 48(9):1501-10. PubMed ID: 17785729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convenient solid-phase synthesis of diethylenetriaminepenta-acetic acid (DTPA)- conjugated cyclic RGD peptide analogues.
    Wang W; McMurray JS; Wu Q; Campbell ML; Li C
    Cancer Biother Radiopharm; 2005 Oct; 20(5):547-56. PubMed ID: 16248770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of bifunctional chelators on biological properties of 111In-labeled cyclic peptide RGD dimers.
    Shi J; Kim YS; Chakraborty S; Zhou Y; Wang F; Liu S
    Amino Acids; 2011 Nov; 41(5):1059-70. PubMed ID: 20052508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts.
    Lee FT; Rigopoulos A; Hall C; Clarke K; Cody SH; Smyth FE; Liu Z; Brechbiel MW; Hanai N; Nice EC; Catimel B; Burgess AW; Welt S; Ritter G; Old LJ; Scott AM
    Cancer Res; 2001 Jun; 61(11):4474-82. PubMed ID: 11389078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new optical and nuclear dual-labeled imaging agent targeting interleukin 11 receptor alpha-chain.
    Wang W; Ke S; Kwon S; Yallampalli S; Cameron AG; Adams KE; Mawad ME; Sevick-Muraca EM
    Bioconjug Chem; 2007; 18(2):397-402. PubMed ID: 17313181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging of alpha(v)beta(3) expression by a bifunctional chimeric RGD peptide not cross-reacting with alpha(v)beta(5).
    Zannetti A; Del Vecchio S; Iommelli F; Del Gatto A; De Luca S; Zaccaro L; Papaccioli A; Sommella J; Panico M; Speranza A; Grieco P; Novellino E; Saviano M; Pedone C; Salvatore M
    Clin Cancer Res; 2009 Aug; 15(16):5224-33. PubMed ID: 19671851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optical imaging of integrin alphavbeta3 expression with near-infrared fluorescent RGD dimer with tetra(ethylene glycol) linkers.
    Liu Z; Liu S; Niu G; Wang F; Liu S; Chen X
    Mol Imaging; 2010 Feb; 9(1):21-9. PubMed ID: 20128995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression.
    Decristoforo C; Faintuch-Linkowski B; Rey A; von Guggenberg E; Rupprich M; Hernandez-Gonzales I; Rodrigo T; Haubner R
    Nucl Med Biol; 2006 Nov; 33(8):945-52. PubMed ID: 17127166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging dose-dependent pharmacokinetics of an RGD-fluorescent dye conjugate targeted to alpha v beta 3 receptor expressed in Kaposi's sarcoma.
    Kwon S; Ke S; Houston JP; Wang W; Wu Q; Li C; Sevick-Muraca EM
    Mol Imaging; 2005; 4(2):75-87. PubMed ID: 16105505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying molecular specificity of alphavbeta3 integrin-targeted optical contrast agents with dynamic optical imaging.
    Gurfinkel M; Ke S; Wang W; Li C; Sevick-Muraca EM
    J Biomed Opt; 2005; 10(3):034019. PubMed ID: 16229663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo evaluation of a novel 99mTc(CO)3-pyrazolyl conjugate of cyclo-(Arg-Gly-Asp-d-Tyr-Lys).
    Alves S; Correia JD; Gano L; Rold TL; Prasanphanich A; Haubner R; Rupprich M; Alberto R; Decristoforo C; Santos I; Smith CJ
    Bioconjug Chem; 2007; 18(2):530-7. PubMed ID: 17373771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tracers for Fluorescence-Guided Surgery: How Elongation of the Polymethine Chain in Cyanine Dyes Alters the Pharmacokinetics of a Dual-Modality c[RGDyK] Tracer.
    Buckle T; van Willigen DM; Spa SJ; Hensbergen AW; van der Wal S; de Korne CM; Welling MM; van der Poel HG; Hardwick JCH; van Leeuwen FWB
    J Nucl Med; 2018 Jun; 59(6):986-992. PubMed ID: 29449447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in brain tumor xenografts.
    Chen X; Conti PS; Moats RA
    Cancer Res; 2004 Nov; 64(21):8009-14. PubMed ID: 15520209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of renal uptake of 111In-DOTA-labeled and A700-labeled RAFT-RGD during integrin αvβ3 targeting using single photon emission computed tomography and optical imaging.
    Briat A; Wenk CH; Ahmadi M; Claron M; Boturyn D; Josserand V; Dumy P; Fagret D; Coll JL; Ghezzi C; Sancey L; Vuillez JP
    Cancer Sci; 2012 Jun; 103(6):1105-10. PubMed ID: 22448775
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.